AD presents cognitive and executive dysfunctions and is biologically defined by the presence of amyloid beta (Aβ) plaques and neurofibrillary tangles containing tau (Long and Holtzman, 2019; Knopman et al., 2021). Here, MAPT is linked to Alzheimer disease.